Methoxy-X04 |
Catalog No.GC10894 |
Methoxy-X04 is a brain-permeable fluorescent probe for amyloid-beta (aβ) designed to detect and quantify plaques, tangles, and cerebrovascular amyloid. It displays high in vitro binding affinity (Ki =26.8 nM) for fibrillar β-sheet deposition.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 863918-78-9
Sample solution is provided at 25 µL, 10mM.
Methoxy-X04 is a fluorescent derivative of Congo Red and Thioflavin T, lacking acidic groups, with a smaller molecular weight and increased lipophilicity. Methoxy-X04 can cross the blood-brain barrier and selectively binds to the beta-sheet structures in dense core amyloid-beta (Aβ) plaques. Methoxy-X04 retains its in vitro binding affinity for amyloid-beta (Aβ) protofibrils, Ki=26.8nM. In vitro, Methoxy-X04 can stain plaques, tangles, and cerebral amyloid angiopathy in post-mortem Alzheimer's disease (AD) brain sections, demonstrating good specificity. In vivo, Methoxy-X04 can be used for imaging Aβ amyloid plaques in the brains of living APP/PS1 mice [1,2].
References:
[1] Bisht K, et al. Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques. J Vis Exp. 2016 Jun 1;(112):54060.
[2] Klunk WE, et al. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol. 2002 Sep;61(9):797-805.
Average Rating: 5
(Based on Reviews and 26 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *